May 14, 2021 12:44 PM IST
- May 14, 2021 12:44 PM IST
- May 13, 2021 08:58 PM IST
Revenue from operations stood at Rs 3,401.56 crore in the quarter under review. It was Rs 3,341 crore in the year-ago period, it added.
- Mar 15, 2021 05:37 PM IST
The company has also set up virtual vaccine help desks across its offices in India to address employee queries on the vaccination including enabling registrations, information on vaccination centres, etc, Piramal Enterprises said in a statement..
- Feb 11, 2021 10:55 PM IST
- Feb 11, 2021 07:59 PM IST
The company had posted a net profit of Rs 724.19 crore for the year-ago period.
- Jan 22, 2021 08:32 PM IST
In a regulatory filing, Piramal Enterprises said it's been issued the Letter of Intent (LoI) by the administrator of DHFL on January 22.
- Jan 15, 2021 08:15 PM IST
An announcement is expected soon. The Committee of Creditors will meet early next week to issue the Letter of Intent to the Piramal Group.
- Jan 12, 2021 12:50 PM IST
Motilal Oswal is bullish on Piramal Enterprises recommended buy rating on the stock with a target price of Rs 1750 in its research report dated January 11, 2021.
- Jan 08, 2021 05:14 PM IST
Piramal Group contests Oaktree's bid for DHFL, strongly objects to at least five claims made by the US asset management company in its bid for DHFL.
- Jan 04, 2021 10:04 PM IST
Wadhawan had proposed to offer 100 percent principal repayment to all the lenders (offered to repay Rs 91,158 crore) as opposed to the next highest bid of Rs 38,250 crore. He has offered to repay Rs 65,000 crore within seven years as opposed to Rs 38,000 crore reportedly payable in 10 years.
- Dec 28, 2020 09:34 AM IST
Piramal raised its total offer for DHFL to Rs 38,250 crore on December 24, higher than Oaktree's offer of Rs 36,400 crore.
- Oct 29, 2020 10:22 AM IST
- Oct 29, 2020 09:44 AM IST
- Oct 28, 2020 05:59 PM IST
The company had posted a net profit of Rs 551.37 crore for the corresponding period of the previous fiscal, Piramal Enterprises said in a regulatory filing.
- Oct 06, 2020 06:18 PM IST
This transaction is one of the largest private equity deals in the Indian pharmaceutical sector. It provides Piramal Pharma Ltd (PPL) growth capital that enables it to invest in accelerated business growth through both organic and inorganic opportunities, the statement said.
- Jul 31, 2020 09:33 AM IST
- Jul 31, 2020 09:33 AM IST
- Jul 30, 2020 04:00 PM IST
The company had posted a net profit of Rs 448.17 crore in the corresponding period of previous fiscal, Piramal Enterprises said in a filing to the BSE.
- Jun 30, 2020 01:54 PM IST
Motilal Oswal is bullish on Piramal Enterprises recommended buy rating on the stock with a target price of Rs 1600 in its research report dated June 28, 2020.
- Jun 29, 2020 10:10 AM IST
The transaction values the pharma business at an enterprise value of USD 2.775 billion (over Rs 20,980 crore), with an upside component of up to USD 360 million
- Jun 27, 2020 03:38 PM IST
The company said it is looking at a range of pharma assets in India and abroad that include branded formulations, manufacturing sites, complex hospital generics and even possibly entering vaccines.
- Jun 23, 2020 06:45 PM IST
The tenure of the instrument is three-years-and-one day and the interest rate is fixed at 9 percent per annum, Piramal Enterprises said.
- Jun 12, 2020 01:25 PM IST
Carlyle might buy the stake in Piramal's pharmaceuticals business for Rs 3,500-4,000 crore
- May 26, 2020 09:08 AM IST